Biocjemical pharmaceutical Industry
In the pharmaceutical industry, there are two related kinds of damage that can happen to a company: reputational damage and damage to the bottom line. Few things impact both of those as much as contamination.
Contamination in the pharmaceutical industry may lead to returned shipments, regulatory oversight, strained relationships with vendors, and increased costs, as well as potential fines, fees, and consent decrees. It’s estimated that contamination can cost a manufacturer 20 to 30 percent of total sales.
Contamination leads to headaches up and down the supply chain; however, the supply chain is also where some of the simplest measures can be taken to reduce the risk of contamination in the pharmaceutical industry. Refining processes and choosing the right equipment within the pharmaceutical supply chain can increase efficiency, improve hygiene, and ensure product safety.
It may be impossible to reduce the chance of contamination to zero, but processes can be improved at every stage of the supply chain in order to lower the likelihood of a contamination event. Here are a few proven methods for reducing contamination in the supply chain.
CPP can help pharmaceutical companies to reduce pollution in their production process. For example, our oblique plug-in boxes with lids use food-grade raw materials, have lids and tamper-proof strips to prevent pollution. Plastic pallets can be used for the storage of raw materials and products as well as finished products. Transportation to reduce exposure to pollution sources。
For instance, automation within the warehouse can create more efficient processes that reduce the need for human intervention. Each step in this direction, however, requires the use of equipment, such as durable plastic pallets, that can handle the rigors and the technical standards of automated systems.
Use More Hygienic Pallets for Shipping
Wood pallets have been the standard in shipping for decades, but in 2009, the pharmaceutical industry learned how costly they could be. Johnson & Johnson recalled over 53 million bottles of Tylenol after consumers reported a bad odor and some became ill. The smell was traced back to wood pallets, but not before the company lost hundreds of millions of dollars due to the recall.